Median and range of carboplatin, cisplatin, daunorubicin and etoposide IC50s in Yoruban and CEPH
Drug | Yoruban | CEPH | ||||
---|---|---|---|---|---|---|
Female (μmol/L) | Male (μmol/L) | Female (μmol/L) | Male (μmol/L) | |||
Carboplatin*,† | 29.1 (15.3–141.1) | 24.6 (11.8–70.3) | 20.4 (10.4–49.2) | 20.1 (8.6–70.4) | ||
Cisplatin† | 7.0 (2.2–37.4) | 6.0 (2.2–27.1) | 5.2 (1.8–25.8) | 5.1 (1.5–73.9) | ||
Daunorubicin* | 0.05 (0.02–0.87) | 0.05 (0.02–0.27) | 0.04 (0.01–0.23) | 0.04 (0.01–0.30) | ||
Etoposide‡ | 0.47 (0.10–17.89) | 0.37 (0.09–5.38) | 0.43 (0.04–7.00) | 0.46 (0.11–17.31) |